Elevated soluble LOX-1 predicts risk of first-time myocardial infarction

Elevated soluble LOX-1 predicts risk of first-time myocardial infarction

AbstractBackground There is an unmet clinical need for novel therapies addressing the residual risk in patients receiving guideline preventive therapy for coronary heart disease. Experimental studies have identified a pro-atherogenic role of the oxidized LDL receptor LOX-1. We investigated the assoc...

Full description

Bibliographic Details
Main Authors: Alexandru Schiopu, Harry Björkbacka, Gayathri Narasimhan, Bi Juin Loong, Gunnar Engström, Olle Melander, Marju Orho-Melander, Jan Nilsson
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Annals of Medicine
Subjects:
LOX-1
myocardial infarction
risk prediction
population cohort
disease mechanisms
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2023.2296552

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2023.2296552

Similar Items